Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 5/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4817499 | 0.81 | KMT2A (0.59) | KMT2ASMN1; SMN2HTTTSHRUSP2 | |
| SCHEMBL4817503 | 0.77 | LMNA (0.71) | KMT2ASMN1; SMN2HTTTSHRUSP2 | |
| SCHEMBL4817495 | 0.77 | LMNA (0.71) | KMT2ASMN1; SMN2HTTTSHRUSP2 | |
| SCHEMBL13416928 | 0.75 | KMT2A (0.68) | KMT2ASMN1; SMN2HTTTSHRUSP2 | |
| SCHEMBL3553134 | 0.75 | SMN1; SMN2 (0.97) | KMT2ASMN1; SMN2HTTTSHRUSP2 | |
| SCHEMBL3539489 | 0.75 | KMT2A (1.00) | KMT2ASMN1; SMN2HTTTSHRUSP2 | |
| SCHEMBL316093 | 0.73 | KMT2A (0.76) | KMT2ASMN1; SMN2HTTTSHRUSP2 | |
| SCHEMBL27722453 | 0.73 | KMT2A (0.76) | KMT2ASMN1; SMN2HTTTSHRUSP2 | |
| SCHEMBL3553965 | 0.73 | TSHR (1.00) | KMT2ASMN1; SMN2HTTTSHRUSP2 | |
| SCHEMBL3546099 | 0.72 | KMT2A (0.79) | KMT2ASMN1; SMN2HTTTSHRUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050245596-A1 | Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss | SMITHKLINE BEECHAM CORPORATION | 2005-11-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245596-A1 | Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss | CTSK, CTSB, CTSD | KMT2A 964/4885SMN1; SMN2 4728/4885HTT 4337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.